Search Results 701-710 of 17682 for corticosteroid

  1. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    ... corticosteroids at physiologic doses ≤ 10 mg/day of prednisone or equivalent are permitted;; Adrenal replacement steroid doses including doses > 10 mg daily ...

  2. A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted Mobile Device Compared with Usual Asthma Care to Treat 6-17 Year Old Patients - Mayo Clinic

    Priority will be given to those with persistent asthma on inhaled corticosteroids ... Unscheduled outpatient visit for asthma requiring oral corticosteroid use; ...

  3. A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

    Initiated low-dose corticosteroid ... Patients on a stable low-dose corticosteroid, bisphosphonate, or denosumab regimen are eligible and may continue treatment.

  4. A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer - Mayo Clinic

    ... corticosteroids, or immunosuppressive drugs) prior to pre-registration. NOTE: Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid ...

  5. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    Subjects receiving intravenous or subcutaneous corticosteroids ... Subjects who are not responsive to oral corticosteroid based on clinical response or blood ...

  6. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    ... corticosteroid administration may be enrolled in this study if all other inclusion/exclusion criteria are met. Other clinically significant co-morbidities ...

  7. Alice Gallo De Moraes, M.D. - Mayo Clinic Faculty Profiles

    Gallo De Moraes also is evaluating the optimal dose of corticosteroids needed for patients with complications from immunotherapy. Advanced modes of ...

  8. A Study to Evaluate the Safety and Effectiveness of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease - Mayo Clinic

    Subject may be receiving corticosteroid therapy provided that the dose is ≤ 1 mg/kg/day of systemic prednisone or equivalent and has been stable for at ...

  9. TD-1473 for Active Ulcerative Colitis (UC) - Mayo Clinic

    If the subject is currently receiving an oral corticosteroid, he or she is eligible if the dose is equivalent to or less than prednisone 20 mg/day or ...

  10. What Are the Most Effective Treatments for Grover's Disease Itching? - Mayo Clinic News Network

    Grover's disease — also known as transient acantholytic dermatosis — is a condition where itchy red spots appear without warning, usually on a person's back or ...